scientific article; zbMATH DE number 3984436
This book is devoted to the statistical methods that are relevant throughout pharmaceutical and chemical research, special attention being paid to the early speculative phase of the research, characterized by large numbers of test compounds. The emphasis is also on methods which impinge more or less directly on the decisions that are made during the course of this kind of research, rather than just on those that are purely informative. Four decision-making areas are considered: the selection of compounds for testing; the design of a screen; the sequencing and allocation of resources between a set of related screens; and the allocation of effort between different projects. The four chapters of the book deal with these areas in turn. The relevant literature is reviewed, and principal methods are described in some detail. To these the authors add some of their own, including some not previously published. The final postscript considers the adequacy of existing statistical procedures in each of the four areas and suggests some extensions and improvements. The book as a whole is aimed at all scientists engaged in the speculative end of new-product chemical research, particularly those with a responsibility for any kind of planning, together with the statisticians and operational researchers who advise them.
- Single machine scheduling when processing times are correlated normal random variables
- On scheduling influential stochastic tasks on a single machine
- Stochastic scheduling and forwards induction
- Models and software for improving the profitability of pharmaceutical research
- Applied statistics in the pharmaceutical industry. With case studies using S-PLUS
- Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies
- A General Model for the Scheduling of Alternative Stochastic Jobs that may Fail
- Optimal selection policies for a sequence of candidate drugs
- scientific article; zbMATH DE number 49706 (Why is no real title available?)
- Statistical methodology for screening studies with qualitative/quantitative mixtures
- Nonclinical statistics for pharmaceutical and biotechnology industries
- Screening
- Optimal decision indices for R\&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index
This page was built for publication:
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3747599)